What question did this study set out to answer?

The aim is to promote the use of non-animal alternatives in research, particularly concerning drug development.

NIH, FDA Announcements Aim to Bolster Animal Alternatives

View Full Paper

Ask AI

Bookmark

FDA and NIH unveil initiatives to advance animal alternatives in research, indicating significant funding and guidance efforts.

The aim is to promote the use of non-animal alternatives in research, particularly concerning drug development.
FDA issued guidance on evaluating non-animal alternatives for pharmacology and toxicology.
NIH allocated over $150 million for the development of additional non-animal methodologies.
Collaboration with cancer researchers to assess the readiness of alternatives.
FDA's guidance marks the first of its kind for non-animal drug evaluation.
NIH funding will support multiple centers focused on new approach methodologies.
Cancer researchers express that existing alternatives are not yet sufficient to fully replace animal models.

A 2026 study studied this question.

View Full Paper

Ask AI

Bookmark